HOUSTON, DECEMBER 24, 2025 ― A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson ...

The anti-CD40 antibody tegoprubart offers a tacrolimus-free immunosuppression option for preventing islet transplant ...

Taken together, these advances suggest that part of age-related immune decline is driven by specific, potentially reversible ...

Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...

Researchers at ETH Zurich recently explained the role of a molecular complex that orchestrates the production of proteins in ...

In August, the corpses of four men were found along the banks of the river in Val-de-Marne, just outside Paris. Le Monde ...

Federal Minister Hanif Abbasi says the ML-1 railway project agreement with the Asian Development Bank has been finalised, ...

Mary Brucato, 23, died of medical neglect while in the throes of fentanyl withdrawal as jail staff allegedly watched her ...

Federal Minister for Pakistan Railways Muhammad Hanif Abbasi said an agreement for the ML-1 project had been finalised with ...

The company plans to announce Phase 1b interim data by mid-2026, and the TENACITY-01 study is expected to be completed by late 2028. This timing enables progression to Phase 2 evaluation following ...

El Salvador's mega-prison known as CECOT is at the centre of President Nayib Bukele's crackdown on crime, U.S. President Donald Trump's anti-immigration policies and the recent controversy about an ...

Pluri (PLUR) announced expansion of its manufacturing agreement signed in 2024 with Remedy Cell. Under the ongoing collaboration Remedy Cell’s ...